Legislature(2023 - 2024)DAVIS 106
03/02/2023 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB52 | |
| HB6 | |
| HB56 | |
| HB17 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 56 | TELECONFERENCED | |
| *+ | HB 6 | TELECONFERENCED | |
| *+ | HB 52 | TELECONFERENCED | |
| + | TELECONFERENCED | ||
| += | HB 17 | TELECONFERENCED | |
HB 56-CONTROLLED SUB. DATA: EXEMPT ANIMAL RX
4:26:21 PM
CHAIR PRAX announced that the next order of business would be
HOUSE BILL NO. 56, "An Act exempting controlled substances
prescribed or dispensed by a veterinarian to treat an animal
from the requirements of the controlled substance prescription
database."
4:26:40 PM
REPRESENTATIVE RUFFRIDGE, as prime sponsor, introduced HB 56 via
a PowerPoint presentation [hard copy included in the committee
packet]. He stated that HB 56 would exempt veterinarians from
the Prescription Drug Monitoring Program (PDMP). Beginning on
slide 2, he stated PDMP had been established in Alaska in 2008
to track the dispensing of controlled substance medications. He
added that while every state has a similar program, 33 states
have exempted veterinarians from participating. Currently in
Alaska all prescribing-license types are required to register
with PDMP. He continued that license holders are required to
review PDMP prior to prescribing controlled substances and
report daily on the dispensing of all controlled substances,
even on days the business is closed.
4:29:11 PM
REPRESENTATIVE RUFFRIDGE, referring to slide 3, stated that PDMP
was designed as a dispensing record to aid practitioners,
especially in relation to [Schedule] II narcotics, which are
highly abusable medications. He listed some of the other lower-
class drugs, which also have to be reported. He said pharmacies
have an automatic daily-reporting process, while veterinarians
manually submit their daily reports. He stated that PDMP
monitors prescriptions for legal drugs and would have no control
over illicit-drug use. He stated that the purpose of PDMP is to
help prevent doctor and pharmacy "shopping."
4:32:21 PM
REPRESENTATIVE RUFFRIDGE, moving to the next slide, addressed
the reason for the legislation. He stated that veterinarians
are aware of the importance of PDMP in preventing pharmaceutical
drug abuse; however, they experience unique difficulties with
the program requirements. He added that there are some serious
concerns about the privacy of information in PDMP. On slide 5,
he pointed out that the program is designed to track human
prescriptions, not animal prescriptions. The data gathered by
veterinarians is often not linked to the animal owner, and this
would be required to accurately track data. Veterinarians are
not guided by the Health Insurance Portability and
Accountability Act (HIPAA), nor are they trained in human
medicine. Before dispensing a controlled substance to an
individual with a pet, the veterinarian is required to look up
information on the individual to see if any previous drugs have
been dispensed. He stated that many pet owners are not aware
veterinarians would have access to personal medical information,
and this could be a concern. Animal patients are not well
tracked because they lack the unique PDMP identifiers, and
individuals connected to the pet may not be consistent.
4:35:12 PM
REPRESENTATIVE RUFFRIDGE continued to slide 7 and stated that
veterinarians rarely require the use of [Schedule] II narcotics.
In a 2017 study, he said, veterinary clinics accounted for only
0.34 percent of all the opioids dispensed. He added that
veterinary clinics would use opioids only during surgery, and
typically opioid dispensing is reserved for pharmacies, not
veterinarians. In summary, he stated that exempting
veterinarians from PDMP would protect privacy and ensure PDMP
data is clear, usable, and linked only to end users.
4:36:21 PM
BUD SEXTON, Staff, Representative Justin Ruffridge, Alaska State
Legislature, on behalf of Representative Ruffridge, prime
sponsor, provided the sectional analysis of HB 56 [copy included
in the committee packet], which read as follows [original
punctuation provided]:
Section 1. AS 17.30.200(o) is amended to remove "and
the Board of Veterinary Examiners" from the
notification requirement when a practitioner registers
with the database under (n) of this section.
Sec. 2. AS 17.30.200 is amended by adding a new
subsection to read: This section does not apply to a
schedule II, III, or IV controlled substance
prescribed or dispensed by a veterinarian licensed
under AS 08.98 to treat an animal.
Sec. 3. AS 08.98.050(a)(10) is repealed which removes
the requirement for Veterinarians under the controlled
substance prescription database.
4:37:42 PM
TRACY WARD, DVM, Clinic Director/Veterinarian, Juneau Animal
Rescue, provided invited testimony in support of HB 56. She
shared that she recently had been the president of the Alaska
State Veterinary Medical Association (AKVMA). She explained
that Dr. Rachel Berngartt was scheduled to testify on behalf of
the Alaska Board of Veterinary Examiners (BOVE); however, Dr.
Berngartt was detained. She stated that she would be presenting
and answering questions on behalf of both AKVMA and BOVE.
DR. WARD stated for the record that both AKVMA and BOVE strongly
support HB 56. She stated that the Alaska Board of Pharmacy,
which administers PDMP, has recently passed a motion to support
the proposed legislation, as seen on slide 3. She stated that
PDMP had been amended in 2017 to require mandatory participation
by all federal permit holders. As seen in the photo on slide 4,
she stated that representatives from the prescribing boards of
other agencies had been consulted in drafting the amendment;
however, veterinarians had not been consulted. In other words,
advice was not sought from BOVE nor AKVMA, but both
organizations were included in the requirements.
4:40:02 PM
DR. WARD, moving to slide 5, stated that PDMP is not a workable
database for veterinarians because the system is designed for
human data. She said this data is uninterpretable because
veterinarians are not trained in human pharmacology and would
not have the knowledge of appropriate doses, medication
timeframes, and refill requirements. Moving to slide 6, she
expressed the opinion that having access to this data is
intrusive and an invasion of human privacy, because humans are
not the patients - they are the clients. She added that
veterinarians are not protected by HIPAA regulations. She
suggested that committee members consider how personal
medication history is being shared outside of client/patient
privilege. She maintained veterinarians are uncomfortable with
this.
DR. WARD, moving to slide 7, stated, if veterinarians were not
monitored through PDMP in regard to controlled substances, they
would be monitored through record keeping with the DEA. She
stated that every pill of oral medication dispensed and every
drop of injectable medication administered has to be accounted
for. Records would be maintained and made available to DEA or
local law enforcement agencies upon request. She added that
distributors of controlled substances are required to monitor
any pattern in usage by the DEA's Suspicious Orders Report
System, and the vast majority of drug diversions are caught
through this process, not PDMP.
4:44:30 PM
DR. WARD reiterated that a very small amount of total opioid
prescriptions would be dispensed by veterinarians. She stated
that if every one of these prescriptions were misused, it would
be "a tiny, tiny drop in the bucket of the total opioid abuse
problems." She pointed out in the graph on slide 9 that, in
general, veterinarians do not use the drugs of concern, and
synthetic opioids are almost never used. She added that Vicodin
or oxycontin are not used; however, fentanyl is used, but
exclusively in the hospital and would not be sent home with the
pet owner. She added that cocaine or methamphetamine is not
used. She maintained that veterinarians would not be the source
of the drugs of concern in the current drug epidemic.
DR. WARD, moving to slide 10, argued that veterinarians are
pursuing the proposed legislation because of the hardship PDMP
creates. She stated that investigations of veterinarians by the
board of PDMP are mostly because of clerical mistakes. Moving
to slide 11, she stated that since participation became
mandatory, investigative costs have increased threefold. She
explained that this is not because veterinarians are misusing
drugs, but because they are required to use an unwieldy system.
She explained that the board is not funded by the government,
but by licensing fees, so the cost of investigating
veterinarians is borne by the veterinarians. In other words,
veterinarians are charged with investigating themselves. She
added that Alaska already has the highest licensing fees in the
country. Moving to slide 12, she stated that support of HB 56
would allow veterinarians to provide appropriate medical
management, while increasing the efficiency of PDMP for its
intended purpose.
4:48:29 PM
REPRESENTATIVE SADDLER questioned how exempting veterinarians
from PDMP would improve efficiency.
REPRESENTATIVE RUFFRIDGE responded that PDMP was intended to
stop doctor and pharmacy "shopping," which had been a common
practice prior to the implementation of the program. He stated
that the inability to track medications dispensed from multiple
sources led to the overprescribing of controlled substances. He
stated that exempting veterinarians would clean up the data.
For example, a prescription for an animal can be in PDMP
multiple times under different pet names or owners, so this data
is difficult to accurately interpret. In turn the data cannot
be trusted, and the purpose of PDMP is not supported.
REPRESENTATIVE SADDLER, with a follow-up question, requested
additional comments on PDMP's intended use and its
effectiveness.
REPRESENTATIVE RUFFRIDGE responded that the program is
effective. He added that unfortunately the overdose deaths in
Alaska are still increasing, and this causes criticism. He
stated that PDMP is successfully adverting people from doctor
and pharmacy "shopping," but abuse of illicit drugs, such as
heroin, oxycodone, and fentanyl, has not been stopped.
4:52:03 PM
REPRESENTATIVE MINA commented that those in opposition of the
proposed legislation have come to a position of neutrality. She
questioned participation by veterinarians in addressing the drug
epidemic.
DR. WARD expressed the opinion that the education of
veterinarians is more worthwhile than requiring participation in
PDMP. She pointed out that speakers from DEA have been invited
to address [the drug epidemic] at the state veterinarians'
conference. She stated that, even though veterinary clinic
"shopping" is very rare, as part of the larger medical
community, veterinarians should be educated. She stated that
veterinarian clinics have been broken into, and security has
been increased. Within the last five years clinics are more
often calling in prescriptions to pharmacies, as opposed to
dispensing controlled drugs on the premises.
DR. WARD, in response to a follow-up question, expressed the
understanding that currently xylazine is in the process of
becoming a federally controlled substance. She expressed the
opinion that this drug would likely not be a problem in Alaska,
because it is a tranquillizer used on large animals, such as
horses, and Alaska has a small proportion of large animals.
4:55:55 PM
DR. WARD, in response to Representative Sumner, stated that
veterinarians use two opioids. Hydrocodone would be of the
primary concern, but it is used in minor amounts for chronic
coughs in small dogs. She added that accessing enough of this
drug from a clinic to cause a serious issue would be difficult.
She stated that buprenorphine would be used in a clinic as a
pain medication. She added that this drug is also used to treat
fentanyl addiction.
4:57:27 PM
REPRESENTATIVE RUFFRIDGE asserted that more work would be done
on HB 56. He stressed the importance of clean data in PDMP and
allowing veterinarians to do their job.
4:58:31 PM
CHAIR PRAX announced that HB 56 was held over.
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB 6 Sectional Analysis .pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 6 |
| HB 6 Sponsor Statement.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 6 |
| HB0006A.PDF |
HHSS 3/2/2023 3:00:00 PM |
HB 6 |
| HB 52 - v.A.PDF |
HHSS 3/2/2023 3:00:00 PM HHSS 3/16/2023 3:00:00 PM |
HB 52 |
| HB 52 - Sponsor Statement.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/16/2023 3:00:00 PM |
HB 52 |
| HB 52 - Sectional Analysis.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/16/2023 3:00:00 PM |
HB 52 |
| HB0056A.PDF |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB56 Sectional Analysis.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB56 Support Letter.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| House Bill 56 Sponsor Statement.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB 56 Fiscal Note.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 56 |
| HB56 Rep.Ruffridge Presentation.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB 56 Hearing Slides 2023 (002).pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| Geiger HB56 Support Ltr - Feb 26 2023 - 7-15 PM.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB56 Delker Support.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| HB56 letter removing opposition vets PDMP.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/11/2023 3:00:00 PM |
HB 56 |
| PDMPFlyer.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 56 |
| HB 56 2023AVKMA-PDMPWhitePaper.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 56 |
| HB56 VerSteeg Support Letter.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 56 |
| HB 6 Kellsie's Lesson Example.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 6 |
| HB 17 Support Document - Public Costs From Unintended Pregnancies February 2015.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Unintended Pregnancies Study March 2011.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - UCSF Study Newspaper Article 2.22.2011.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - HRSA Women's Preventive Services Guidelines.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Insurance Coverage of Contraceptives 4.01.2021.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Document - Guttmacher Alaska Statistics 2016.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 v. A Sponsor Statement.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB17 Version A.PDF |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 v. A Sectional Analysis.pdf |
HHSS 2/7/2023 3:00:00 PM HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Support Letter.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| Opposition Letter for HB 17 Redacted.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| ACOGFactsAreImportantEC.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| FDA Decisional Memorandum 12.23.2022.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Opposition Letter Redacted 3.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 opposition letters 4 Redacted.pdf |
HHSS 2/18/2023 3:00:00 PM HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| ALPHA Policy Comm Letter of Support HB17 2-10-23.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB17.SB27 LOS 2.23 ANDVSA.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 17 SB 27 |
| A.1--amendment to HB 17 Contraceptives.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 17 Opposition Letters Redacted 2.pdf |
HHSS 3/2/2023 3:00:00 PM |
HB 17 |
| HB 52 - Slideshow Presentation (03-01-23).pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/16/2023 3:00:00 PM |
HB 52 |
| HB 17 Fiscal Note DCCED.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 17 |
| HB 17 Fiscal Note DOA-DRB.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 17 |
| HB 17 Fiscal Note DOH.pdf |
HHSS 3/2/2023 3:00:00 PM HHSS 3/7/2023 3:00:00 PM |
HB 17 |